Shortening the incubation time for the combination disk diffusion extended-spectrum beta-lactarnase (ESBL) confirmation test: how far can we go?

Wouter Bijllaardt; PCM Voermans; AG Buiting; Johan Mouton; Anouk Muller

doi:10.1016/j.ijantimicag.2017.03.032

Shortening the incubation time for the combination disk diffusion extended-spectrum beta-lactarnase (ESBL) confirmation test: how far can we go?

Wouter Bijllaardt, PCM Voermans, AG Buiting, Johan Mouton, Anouk Muller

Medical Microbiology & Infectious Diseases

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	473-476
Number of pages	4
Journal	International Journal of Antimicrobial Agents
Volume	50
Issue number	3
DOIs	https://doi.org/10.1016/j.ijantimicag.2017.03.032
Publication status	Published - 2017

Research programs

EMC MM-04-28-01

Access to Document

10.1016/j.ijantimicag.2017.03.032

http://hdl.handle.net/1765/101024

Cite this

@article{eab75de1bd284c36899057fc74bad1d0,

title = "Shortening the incubation time for the combination disk diffusion extended-spectrum beta-lactarnase (ESBL) confirmation test: how far can we go?",

author = "Wouter Bijllaardt and PCM Voermans and AG Buiting and Johan Mouton and Anouk Muller",

year = "2017",

doi = "10.1016/j.ijantimicag.2017.03.032",

language = "Undefined/Unknown",

volume = "50",

pages = "473--476",

journal = "International Journal of Antimicrobial Agents",

issn = "0924-8579",